Home / Health / Boston Hospitals in Fierce Cancer Care Rivalry
Boston Hospitals in Fierce Cancer Care Rivalry
12 Feb
Summary
- Mass General Brigham is phasing out Dana-Farber physician assistants.
- The split between Dana-Farber and Brigham is escalating quickly.
- This competition could lead to higher healthcare spending.

The partnership between Boston's Dana-Farber and Brigham and Women's Hospital is dissolving faster than anticipated, escalating into a contentious dispute over physician assistants. Mass General Brigham, Brigham's parent company, is phasing out Dana-Farber physician assistants by the end of 2026, impacting their employment status.
This conflict is intensifying competition between the two major cancer centers. Experts warn this dynamic could trigger a medical arms race, driving up healthcare spending through significant investments in technology and staff recruitment. The rivalry also poses a risk to smaller community hospitals.
Originally planned for a gradual unwinding by 2028, the split has become messy. Both institutions are now aggressively competing to solidify their positions as leading cancer care providers, signaling a potentially volatile future for healthcare in Boston.




